Sponsor Dossier
Servier Laboratories (Aust)
Sponsor Dossier for Servier Laboratories (Aust). ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: AGOMELATINE-WGR
- Brand: APX-PERINDOPRIL
- Brand: ARDIX
- Brand: CORALAN
- Brand: COVERAM
- Brand: COVERSYL
- Brand: DIAMICRON
- Brand: DOMION
About
Servier Laboratories (Aust) is an Australian Private Company with ABN 54004838500, based in Victoria, with Active entity status.
Portfolio
Servier Laboratories (Aust) has 25 brands on the ARTG, of which 23 are indexable and have Product Information on file. Four brands in the portfolio are PBS-listed, eight have PBAC outcomes on record, and two have AusPARs on record. Notable brands include AGOMELATINE-WGR, APX-PERINDOPRIL, ARDIX, CORALAN, COVERAM, COVERSYL, DIAMICRON, DOMION, IDAPREX, LATUDA, LONSURF, and NATRILIX.
Therapeutic focus —
Cardiology: 11 brands — Oncology: 6 brands — Neurology: 6 brands — Endocrinology: 2 brands
PBS footprint
Four brands in the Servier Laboratories (Aust) portfolio are PBS-listed, with the portfolio most recently touching the PBS schedule on 1 May 2026.
Regulatory activity
The portfolio has eight brands with PBAC outcomes on record, with the latest PBAC outcome dated 1 July 2025. Two brands have AusPARs on record, with the latest AusPAR dated 4 April 2023.